Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

Detalles Bibliográficos
Autores principales: García-Guerrero, Estefanía, Götz, Ralph, Doose, Sören, Sauer, Markus, Rodríguez-Gil, Alfonso, Nerreter, Thomas, Kortüm, K. Martin, Pérez-Simón, José A., Einsele, Hermann, Hudecek, Michael, Danhof, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727283/
https://www.ncbi.nlm.nih.gov/pubmed/34845317
http://dx.doi.org/10.1038/s41375-021-01355-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727283/
https://www.ncbi.nlm.nih.gov/pubmed/34845317
http://dx.doi.org/10.1038/s41375-021-01355-6

Ejemplares similares